BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu J, Liu D, Tan Y, Deng F, Li R. M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation. J Cell Mol Med 2021;25:3041-50. [PMID: 33569850 DOI: 10.1111/jcmm.16348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu J, Liu D, Tan Y, Deng F, Li R. M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation. J Cell Mol Med 2021;25:3041-50. [PMID: 33569850 DOI: 10.1111/jcmm.16348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Reference Citation Analysis]
3 Zhang D, Zhang JT, Pan Y, Liu XF, Xu JW, Cui WJ, Qiao XR, Dong L. Syndecan-1 Shedding by Matrix Metalloproteinase-9 Signaling Regulates Alveolar Epithelial Tight Junction in Lipopolysaccharide-Induced Early Acute Lung Injury. J Inflamm Res 2021;14:5801-16. [PMID: 34764672 DOI: 10.2147/JIR.S331020] [Reference Citation Analysis]
4 Xing Y, Sun X, Dou Y, Wang M, Zhao Y, Yang Q, Zhao Y. The Immuno-Modulation Effect of Macrophage-Derived Extracellular Vesicles in Chronic Inflammatory Diseases. Front Immunol 2021;12:785728. [PMID: 34975877 DOI: 10.3389/fimmu.2021.785728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Stiegeler S, Mercurio K, Iancu MA, Corr SC. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability. Cells 2021;10:3358. [PMID: 34943865 DOI: 10.3390/cells10123358] [Reference Citation Analysis]
6 Ma S, Zhang J, Liu H, Li S, Wang Q. The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease. Front Cell Dev Biol 2022;10:896591. [PMID: 35721513 DOI: 10.3389/fcell.2022.896591] [Reference Citation Analysis]
7 Sunaga S, Tsunoda J, Teratani T, Mikami Y, Kanai T. Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology. Front Immunol 2022;13:867351. [DOI: 10.3389/fimmu.2022.867351] [Reference Citation Analysis]
8 Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Reference Citation Analysis]
9 Ye J, Liu X. Macrophage-Derived Small Extracellular Vesicles in Multiple Diseases: Biogenesis, Function, and Therapeutic Applications. Front Cell Dev Biol 2022;10:913110. [DOI: 10.3389/fcell.2022.913110] [Reference Citation Analysis]
10 Wang X, Zhou G, Zhou W, Wang X, Wang X, Miao C. Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease. Pharmaceutics 2021;13:1644. [PMID: 34683937 DOI: 10.3390/pharmaceutics13101644] [Reference Citation Analysis]